Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hepatitis C virus (HCV) infection is one of the commonest causes of liver cirrhosis and hepatocellular carcinoma. This review deals with treatment of chronic HCV infection with a combination of interferon and ribavirin. Recent trials have shown that approximately 40% of patients will clear HCV with combination treatment. This is an important advance in the treatment of this serious viral infection.

Type

Journal article

Journal

Hosp Med

Publication Date

05/1999

Volume

60

Pages

357 - 361

Keywords

Antiviral Agents, Carcinoma, Hepatocellular, Drug Therapy, Combination, Hepatitis C, Chronic, Humans, Interferon-alpha, Liver Cirrhosis, Liver Neoplasms, Recombinant Proteins, Recurrence, Ribavirin